SCHEMBL4436164

SCHEMBL4436164

O=C(Cl)N1C=CC=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28670350 0.98
SCHEMBL27674320 0.82
SCHEMBL28032704 0.82
SCHEMBL933257 0.80
Hydrochloric Acid SCHEMBL21408262 0.78
SCHEMBL932027 0.78
SCHEMBL28323379 0.78
Hydrochloric Acid SCHEMBL933127 0.77
Formaldehyde SCHEMBL27690920 0.77
Hydrochloric Acid SCHEMBL27863821 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 CN disclosed
CN-116669722-A Interleukin-1 receptor-related kinase (IRAK) degradants and uses thereof 凯麦拉医疗公司 2023-08-29 CN disclosed
CN-115925711-A Substituted pyrazolo [1,5-a ] pyrimidines and their use in treating medical disorders BIAL研发投资股份有限公司 2023-04-07 CN disclosed
CN-107001379-B Substituted pyrazolo [1,5-a ] pyrimidines and their use in the treatment of medical disorders BIAL研发投资股份有限公司 2022-11-01 CN disclosed
CN-110114343-B Pyrazolopyrimidine compounds and methods of use thereof 豪夫迈·罗氏有限公司 2022-09-06 CN disclosed
CN-109890829-B Pyrazolo [1,5a ] pyrimidine derivatives as IRAK4 modulators 豪夫迈·罗氏有限公司 2022-07-15 CN disclosed
CN-110494434-B Pyrazolophenyl compounds, compositions thereof, and methods of use thereof 豪夫迈·罗氏有限公司 2022-05-24 CN disclosed
CN-109970743-B 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds as JAK inhibitors 豪夫迈·罗氏有限公司 2022-03-04 CN disclosed
CN-110003209-B Macrocyclic compounds as TRK kinase inhibitors 阵列生物制药公司 2022-01-25 CN disclosed
CN-108473498-B Pyrazolo [1,5a ] pyrimidine derivatives as IRAK4 modulators 豪夫迈·罗氏有限公司 2021-11-02 CN disclosed
CN-105693720-A Macrocyclic compounds as TRK kinase inhibitors 阵列生物制药公司 2016-06-22 CN disclosed
CN-102971322-B Macrocyclic compounds as TRK kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-02-17 CN disclosed
CN-102633745-B Alpha-methoxy imino group-4-methyl-1, 2, 3-thiadiazole-5-methyl carboxylic ester derivatives and preparation method and application thereof UNIV NANKAI 2014-06-18 CN disclosed
CN-102971322-A Macrocyclic compounds as TRK kinase inhibitors ARRAY BIOPHARMA INC 2013-03-13 CN disclosed
CN-102633745-A Alpha-methoxy imino group-4-methyl-1, 2, 3-thiadiazole-5-methyl carboxylic ester derivatives and preparation method and application thereof UNIV NANKAI 2012-08-15 CN disclosed
CN-101801972-A Pyrazolo [1,5-A]pyrimidines as inhibitors of stearoyl-coA desaturase INOVACIA AB 2010-08-11 CN disclosed
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP disclosed
CN-100528876-C Pyrrazolo-pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2009-08-19 CN disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed
CN-1964973-A Pyrrazolo-pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2007-05-16 CN disclosed